A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.

Kaoru Fujinami, Noemi Lois, Rajarshi Mukherjee, Vikki A. McBain, Kazushige Tsunoda, Kazuo Tsubota, Edwin M. Stone, Fred W. Fitzke, Catey Bunce, Anthony T. Moore, Andrew R. Webster, Michel Michaelides

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

We characterized subtypes of fundus autofluorescence (AF) and the progression of retinal atrophy, and correlated these findings with genotype in Stargardt disease. Full clinical examination and AF imaging was undertaken in 68 patients with Stargardt disease. The baseline data were compared to those at follow-up. Patients were classified into three AF subtypes: type 1 had a localized low signal at the fovea surrounded by a homogeneous background, type 2 had a localized low signal at the macula surrounded by a heterogeneous background with numerous foci of abnormal signal, and type 3 had multiple low signal areas at the posterior pole with a heterogeneous background. At baseline, there were 19 patients with type 1, 41 with type 2, and 8 with type 3 disease. The areas of reduced AF signal were measured and rate of atrophy enlargement (RAE) was calculated as the difference of the atrophy size over time (mm2) divided by the follow-up interval (years). Molecular screening of ABCA4 was undertaken. The mean follow-up interval was 9.1 years. A total of 42% cases with type 1 disease progressed to type 2, and 12% with type 2 progressed to type 3. The RAE (mm2/y) based upon baseline AF subtypes was significantly different; 0.06 in type 1, 0.67 in type 2, and 4.37 in type 3. ABCA4 variants were identified in 57 patients. There was a significant association between AF subtype and genotype. The AF pattern at baseline influences the enlargement of atrophy over time and has genetic correlates. These data are likely to assist in the provision of counseling on prognosis in Stargardt disease and be valuable for future clinical trials.

Original languageEnglish
Pages (from-to)8181-8190
Number of pages10
JournalInvestigative ophthalmology & visual science
Volume54
Issue number13
Publication statusPublished - 2013 Dec
Externally publishedYes

Fingerprint

Atrophy
Longitudinal Studies
Genotype
Optical Imaging
Counseling
Stargardt disease 1
Clinical Trials

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A longitudinal study of Stargardt disease : quantitative assessment of fundus autofluorescence, progression, and genotype correlations. / Fujinami, Kaoru; Lois, Noemi; Mukherjee, Rajarshi; McBain, Vikki A.; Tsunoda, Kazushige; Tsubota, Kazuo; Stone, Edwin M.; Fitzke, Fred W.; Bunce, Catey; Moore, Anthony T.; Webster, Andrew R.; Michaelides, Michel.

In: Investigative ophthalmology & visual science, Vol. 54, No. 13, 12.2013, p. 8181-8190.

Research output: Contribution to journalArticle

Fujinami, K, Lois, N, Mukherjee, R, McBain, VA, Tsunoda, K, Tsubota, K, Stone, EM, Fitzke, FW, Bunce, C, Moore, AT, Webster, AR & Michaelides, M 2013, 'A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.', Investigative ophthalmology & visual science, vol. 54, no. 13, pp. 8181-8190.
Fujinami, Kaoru ; Lois, Noemi ; Mukherjee, Rajarshi ; McBain, Vikki A. ; Tsunoda, Kazushige ; Tsubota, Kazuo ; Stone, Edwin M. ; Fitzke, Fred W. ; Bunce, Catey ; Moore, Anthony T. ; Webster, Andrew R. ; Michaelides, Michel. / A longitudinal study of Stargardt disease : quantitative assessment of fundus autofluorescence, progression, and genotype correlations. In: Investigative ophthalmology & visual science. 2013 ; Vol. 54, No. 13. pp. 8181-8190.
@article{49f43ad8e3be4eff902043aba904a1de,
title = "A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.",
abstract = "We characterized subtypes of fundus autofluorescence (AF) and the progression of retinal atrophy, and correlated these findings with genotype in Stargardt disease. Full clinical examination and AF imaging was undertaken in 68 patients with Stargardt disease. The baseline data were compared to those at follow-up. Patients were classified into three AF subtypes: type 1 had a localized low signal at the fovea surrounded by a homogeneous background, type 2 had a localized low signal at the macula surrounded by a heterogeneous background with numerous foci of abnormal signal, and type 3 had multiple low signal areas at the posterior pole with a heterogeneous background. At baseline, there were 19 patients with type 1, 41 with type 2, and 8 with type 3 disease. The areas of reduced AF signal were measured and rate of atrophy enlargement (RAE) was calculated as the difference of the atrophy size over time (mm2) divided by the follow-up interval (years). Molecular screening of ABCA4 was undertaken. The mean follow-up interval was 9.1 years. A total of 42{\%} cases with type 1 disease progressed to type 2, and 12{\%} with type 2 progressed to type 3. The RAE (mm2/y) based upon baseline AF subtypes was significantly different; 0.06 in type 1, 0.67 in type 2, and 4.37 in type 3. ABCA4 variants were identified in 57 patients. There was a significant association between AF subtype and genotype. The AF pattern at baseline influences the enlargement of atrophy over time and has genetic correlates. These data are likely to assist in the provision of counseling on prognosis in Stargardt disease and be valuable for future clinical trials.",
author = "Kaoru Fujinami and Noemi Lois and Rajarshi Mukherjee and McBain, {Vikki A.} and Kazushige Tsunoda and Kazuo Tsubota and Stone, {Edwin M.} and Fitzke, {Fred W.} and Catey Bunce and Moore, {Anthony T.} and Webster, {Andrew R.} and Michel Michaelides",
year = "2013",
month = "12",
language = "English",
volume = "54",
pages = "8181--8190",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "13",

}

TY - JOUR

T1 - A longitudinal study of Stargardt disease

T2 - quantitative assessment of fundus autofluorescence, progression, and genotype correlations.

AU - Fujinami, Kaoru

AU - Lois, Noemi

AU - Mukherjee, Rajarshi

AU - McBain, Vikki A.

AU - Tsunoda, Kazushige

AU - Tsubota, Kazuo

AU - Stone, Edwin M.

AU - Fitzke, Fred W.

AU - Bunce, Catey

AU - Moore, Anthony T.

AU - Webster, Andrew R.

AU - Michaelides, Michel

PY - 2013/12

Y1 - 2013/12

N2 - We characterized subtypes of fundus autofluorescence (AF) and the progression of retinal atrophy, and correlated these findings with genotype in Stargardt disease. Full clinical examination and AF imaging was undertaken in 68 patients with Stargardt disease. The baseline data were compared to those at follow-up. Patients were classified into three AF subtypes: type 1 had a localized low signal at the fovea surrounded by a homogeneous background, type 2 had a localized low signal at the macula surrounded by a heterogeneous background with numerous foci of abnormal signal, and type 3 had multiple low signal areas at the posterior pole with a heterogeneous background. At baseline, there were 19 patients with type 1, 41 with type 2, and 8 with type 3 disease. The areas of reduced AF signal were measured and rate of atrophy enlargement (RAE) was calculated as the difference of the atrophy size over time (mm2) divided by the follow-up interval (years). Molecular screening of ABCA4 was undertaken. The mean follow-up interval was 9.1 years. A total of 42% cases with type 1 disease progressed to type 2, and 12% with type 2 progressed to type 3. The RAE (mm2/y) based upon baseline AF subtypes was significantly different; 0.06 in type 1, 0.67 in type 2, and 4.37 in type 3. ABCA4 variants were identified in 57 patients. There was a significant association between AF subtype and genotype. The AF pattern at baseline influences the enlargement of atrophy over time and has genetic correlates. These data are likely to assist in the provision of counseling on prognosis in Stargardt disease and be valuable for future clinical trials.

AB - We characterized subtypes of fundus autofluorescence (AF) and the progression of retinal atrophy, and correlated these findings with genotype in Stargardt disease. Full clinical examination and AF imaging was undertaken in 68 patients with Stargardt disease. The baseline data were compared to those at follow-up. Patients were classified into three AF subtypes: type 1 had a localized low signal at the fovea surrounded by a homogeneous background, type 2 had a localized low signal at the macula surrounded by a heterogeneous background with numerous foci of abnormal signal, and type 3 had multiple low signal areas at the posterior pole with a heterogeneous background. At baseline, there were 19 patients with type 1, 41 with type 2, and 8 with type 3 disease. The areas of reduced AF signal were measured and rate of atrophy enlargement (RAE) was calculated as the difference of the atrophy size over time (mm2) divided by the follow-up interval (years). Molecular screening of ABCA4 was undertaken. The mean follow-up interval was 9.1 years. A total of 42% cases with type 1 disease progressed to type 2, and 12% with type 2 progressed to type 3. The RAE (mm2/y) based upon baseline AF subtypes was significantly different; 0.06 in type 1, 0.67 in type 2, and 4.37 in type 3. ABCA4 variants were identified in 57 patients. There was a significant association between AF subtype and genotype. The AF pattern at baseline influences the enlargement of atrophy over time and has genetic correlates. These data are likely to assist in the provision of counseling on prognosis in Stargardt disease and be valuable for future clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=84894541201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894541201&partnerID=8YFLogxK

M3 - Article

C2 - 24265018

AN - SCOPUS:84894541201

VL - 54

SP - 8181

EP - 8190

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 13

ER -